- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01646476
Covered Versus Uncovered Self-expandable Metallic Stents for Malignant Gastric Outlet Obstruction
Comparison of Efficacy of Covered Versus Uncovered Self-expandable Metallic Stents for Treatment of Malignant Gastric Outlet Obstruction: a Prospective, Randomized Study
Malignant gastric outlet obstruction can result from gastric adenocarcinoma, leading to intractable vomiting, nausea, and poor oral food intake. Although self-expandable metallic stent (SEMS) insertion has excellent technical and clinical success rates for relieving gastric outlet obstruction symptoms, the uncovered SEMS is susceptible to re-stenosis because of tumor ingrowth through openings between the stent wire filaments. Therefore, the most common reason for stent failure in uncovered stents is tumor ingrowth.
The covered SEMS has a membrane that prevents ingrowth through the mesh wall and consequently shows lower rate of re-stenosis than uncovered SEMS. However, covered SEMS has a higher risk of stent migration compared to uncovered SEMS. Recent prospective, randomized study showed that there was no significant difference between uncovered and covered SEMS in terms of stent patency rate as well as technical and clinical success rates.
Recently the investigators developed new covered SEMS for gastric outlet obstruction. This new covered SEMS has features that may contribute to reducing migration rate: 1) partially covered design; 2)less radial force in central portion of stent; 3) presence of lasso which enable position of stent to be adjusted after deployment; 4)presence of protrusion in both sides of stent. This prospective, randomized study aimed to compare the effectiveness and side effects of newly developed covered SEMS with those of uncovered SEMS in patients with malignant gastric outlet obstruction from gastric cancer.
Study Overview
Status
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of
- Samsung Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age: 20-80
- patients with gastric outlet obstruction due to gastric adenocarinoma
- patients with inoperable gastric adenocarcinoma due to distant metastasis or severe comorbidity
- Gastric outlet obstruction score: 0-2
- Symptoms consistent with gastric outlet obstruction such as nausea or vomiting
- Findings consistent with gastric outlet obstruction in upper endoscopy or abdominal computed tomography
Exclusion Criteria:
- Previous history of stent insertion or endoscopic dilation for gastric outlet obstruction
- previous history of bypass surgery for gastric outlet obstruction
- Multiple level of bowel obstruction confirmed in radiographic studies such as small bowel series or abdominal computed tomography
- Borrmann type IV advanced gastric cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Covered stent (Bona stent, pyloric/duodenal covered)
WAVE covered self-expandable metallic stent (BONASTENT, Standard Sci Tech, Ltd., Seoul, Korea)
|
self-expandable metallic stent placement was performed with a therapeutic endoscope (working channel ≥ 3.7 mm) using a through-the-scope method.
All patients underwent procedures under conscious sedation with midazolam and pethidine.
The length of the stricture was assessed either endoscopically or fluoroscopically; the length of the stent had to exceed that of the stricture by at least 3 cm.
After the required stent length was determined, the stent was advanced through the endoscope over a guidewire until it passed across the distal end of the stricture.
Then, the stent was deployed under continuous fluoroscopic control.
For the Wave covered stent group, the stent was repositioned after deployment using the lasso under fluoroscopic guidance (if necessary), aligning the central portion of the stricture with the central portion of the stent which had reduced radial force and indentation.
Stent positioning was confirmed endoscopically and fluoroscopically.
|
ACTIVE_COMPARATOR: Uncovered stent (Bona stent, pyloric/duodenal)
uncovered self-expandable metallic stent (BONASTENT, Standard Sci Tech, Ltd., Seoul, Korea)
|
Self-expandable metallic stent placement was performed with a therapeutic endoscope (working channel ≥ 3.7 mm) using a through-the-scope method.
All patients underwent procedures under conscious sedation with midazolam and pethidine.
The length of the stricture was assessed either endoscopically or fluoroscopically; the length of the stent had to exceed that of the stricture by at least 3 cm.
After the required stent length was determined, the stent was advanced through the endoscope over a guidewire until it passed across the distal end of the stricture.
Then, the stent was deployed under continuous fluoroscopic control.
For the Wave covered stent group, the stent was repositioned after deployment using the lasso under fluoroscopic guidance (if necessary), aligning the central portion of the stricture with the central portion of the stent which had reduced radial force and indentation.
Stent positioning was confirmed endoscopically and fluoroscopically.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Stent patency
Time Frame: 8 weeks after stent insertion
|
8 weeks after stent insertion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Stent patency
Time Frame: 16 weeks after stent insertion
|
16 weeks after stent insertion
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-01-075
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Outlet Obstruction Due to Gastric Adenocarcinoma
-
National Cancer Center, KoreaStent research group, Korean Society of Gastrointestinal Endoscopy, KoreaUnknownGastric Outlet Obstruction Due to MalignancyKorea, Republic of
-
Coordinación de Investigación en Salud, MexicoRecruitingMalignant Gastric Outlet ObstructionMexico
-
AdventHealthRecruitingMalignant Gastric Outlet ObstructionUnited States
-
Spectrum Health HospitalsRecruitingMalignant Gastric Outlet ObstructionUnited States
-
National Taiwan University HospitalNot yet recruitingMalignant Gastric Outlet Obstruction
-
Asan Medical CenterUnknownMalignant Gastric Outlet ObstructionKorea, Republic of
-
Chinese University of Hong KongNational University Hospital, Singapore; Singapore General Hospital; Changi General... and other collaboratorsCompletedUnresectable Malignant Gastric Outlet ObstructionChina
-
Case Comprehensive Cancer CenterRecruitingMalignant Gastric Outlet Obstruction | Malignant Small Bowel ObstructionUnited States
-
Istituto Clinico HumanitasRecruitingMalignant Biliary ObstructionItaly
-
Chinese University of Hong KongCompletedGastric Outlet ObstructionHong Kong
Clinical Trials on Covered stent (Bona stent pyloric/duodenal covered) insertion
-
Shanghai Jiao Tong University School of MedicineUnknownIntracranial AneurysmsChina
-
Chinese University of Hong KongNational University Hospital, Singapore; Singapore General Hospital; Changi General... and other collaboratorsCompletedUnresectable Malignant Gastric Outlet ObstructionChina
-
Yonsei UniversityUnknownColorectal CancerKorea, Republic of
-
Foundation for Liver ResearchCompletedEsophageal Cancer | Esophageal StenosisNetherlands
-
Boston Scientific CorporationCompletedSymptomatic Ischemic Saphenous Vein Graft DiseaseUnited States, Canada
-
Taewoong Medical Co., Ltd.CompletedPancreatic Cancer | Cancer of Bile DuctKorea, Republic of, Japan
-
Soon Chun Hyang UniversityUnknownBile Duct Obstruction | Klatskin's TumorKorea, Republic of
-
Atrium Medical CorporationCompleted
-
NHS National Waiting Times Centre BoardCompletedStent Thrombosis | Coronary Stent Occlusion | Coronary Artery PerforationUnited Kingdom